Here's a look at the ARK Invest Sells for June 15, 2021.
Here's a look at what ARK Invest ETFs sold on September 8, 2021.
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Here's a look at the ARK Invest sells for August 13, 2021.
Here's a look at the ARK Invest sells for August 19, 2021.
Here's a look at the ARK Invest sells for August 18, 2021.
Some Ebola-related stocks had been heavily shorted as they were considered by many investors as the next would-be stock bubble from a major news event.
The three major US stock indexes opened roughly flat this morning as Spanish 10-year bond yields rose to 7.5% and Moody’s cut Germany’s outlook to ‘negative’ after the markets closed last...
Here are Tuesday's leaders and laggards in the premarket session. Energy stocks were the day's big winners early on.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include American Electric Power, Broadcom, Ford, General Motors, JD.com, Sarepta Therapeutics and Valeant Pharmaceuticals.
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
The include top analyst upgrades, downgrades and other research calls from Wednesday Akamai Technologies, Apple, AutoZone, Dropbox, Electronic Arts, Ford, Kinder Morgan, Pandora Media, Procter &...
Here are three biotechs that just recently announced successful Phase 2 trial data for drugs with very big addressable markets.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, AT&T, Autodesk, Bluebird Bio, Monsanto and Sarepta Therapeutics.
Investors and traders alike always seem to be on the lookout for new investment ideas. With the S&P 500 and the Dow Jones Industrial Average having recently hit new highs, 24/7 Wall St. decided...